Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Revel Collective Regulatory News (TRC)

  • This share is currently suspended. It was suspended at a price of 0.025
  • There is currently no data for TRC

Acquisition

15 Jan 2007 07:01

Trinity Capital PLC15 January 2007 15 January 2007 Trinity Capital PLC ("Trinity") Announces the acquisition of a strategic stake in Fortis Healthcare Trinity is pleased to announce that it has agreed to acquire a strategicshareholding in Fortis Healthcare Limited ('FHL'), one of the largest privatehealthcare companies in India(1). Trinity will acquire 2 million shares for£3.37 million. FHL is a healthcare company based in Delhi with operations in Delhi, Noida,Mohali, Amritsar, Faridabad, Raipur and Srinagar. It was established in 1996 bythe promoters of Ranbaxy Laboratories ('the Group'), Trinity intends toparticipate as a shareholder in the future growth of FHL. By acquiring such a stake in FHL, Trinity will seek to gain access toopportunities relating to FHL's plans to expand its network of hospitals fromits current base of 12. Healthcare facilities are also needed in existingtownships to enhance quality of life for residents. This investment thuscarries potential for Trinity as a strategic real estate platform. FHL has filed a Draft Red Herring Prospectus ("DRHP") with the Securities andExchange Board of India ("SEBI") in relation to the proposed Initial PublicOffer ("IPO") on 29th September 2006. Subsequently, FHL has also signed pre-IPOinvestment agreements with Quantum (M) Limited, Blue Ridge Limited Partnershipand Blue Ridge Offshore Master Limited Partnership. Since Trinity's inception in April 2006, we have announced seven transactions,including two similar deals: firstly with ITNL covering the transport sector,and secondly a $100 million partnership with IL&FS for investments in realestate and infrastructure. Trinity believes that the education and health caresectors have largely been ignored by developers in India, and that these arecritical growth sectors. Indeed, medical tourism is one of the fastest growingsub sectors of the Indian service economy. Approximately 180, 000 patientsarrived in 2004 from all over the world, and the medical tourism market wasestimated at US$333million in 2004 and is expected to grow to $2 billion by 2012(IBEF report on healthcare). By developing health care assets, Trinity willintend to participate in the related real estate opportunities that accruealongside the developments. Aashish Kalra, Managing Director of Trikona Capital, said: "Our investment inFHL represents an important strategic stake in a successful and rapidly growingbusiness, which will give us exposure to some of India's largest healthcareprojects and the resulting spin-off opportunities to develop the surroundingreal estate. In addition, we believe there are multiple opportunities tointroduce FHL as our preferred partner in our other developments where there isdemand for hospitals or healthcare facilities." ENDS Enquiries: Trikona Capital Aashish Kalra +91 11 2620 7257 Cardew Group Tim Robertson +44 20 7930 0777 Sofia Rehman Catherine Maitland (London) Gutenberg Communications Harjiv Singh (New York) +1 917 623 7793 Pranav Kumar (Delhi) +91 98100 77898 Numis Iain McDonald +44 20 7776 1567 Notes: • For further information and regular updates regarding the Fund's activities, please log on and sign up for news alerts at www.trinityplc.com This press release is not an offer for sale within the United States of anyequity shares or any other security of Fortis Healthcare Limited. Securities ofFortis Healthcare Limited, including any offering of equity shares, may not beoffered or sold in the United States absent registration under U.S. securitieslaws or an exemption from the registration requirements under such laws. Theproposed offering of Fortis Healthcare Limited securities described in thispress release has not been and will not be registered under U.S. Securitieslaws, and accordingly, any offer or sales of these securities may be made onlyin transaction exempt from registration. An offer of the GDSs has not been made and will not be made to the public in theUnited Kingdom within the meaning of section 102B of the Financial Services andMarkets Act 2000 (as amended) (FSMA) except to legal entities which areauthorized or regulated to operate in the financial markets or, if not soauthorized or regulated, whose corporate purpose is solely to invest insecurities or otherwise in circumstances which do not require the publication bythe company of a prospectus pursuant to the Prospectus Rules of the FinancialServices Authority (FSA). An invitation or inducement to engage in investmentactivity (within the meaning of section 21 of FSMA) has only been communicatedand will only be communicated to persons who have professional experience inmatters relating to investments falling with Article 19(5) of the FinancialServices and Markets Act 2000 (Financial Promotion) Order 2005 or incircumstances in which section 21 of FSMA does not apply to the company. Allapplicable provisions of FSMA has been and will be complied with regarding allactivity in relation to the GDSs in, from or otherwise involving the UnitedKingdom. -------------------------- (1) Based on the number of hospital beds according to CRIS-INFAC Report 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Mar 20267:00 amRNSCancellation - The Revel Collective Plc
27th Jan 20266:00 pmRNSThe Revel Collective
27th Jan 20262:05 pmRNSDisclosure Table
27th Jan 20261:17 pmRNSAppointment of Administrators & Nomad Resignation
26th Jan 202612:33 pmRNSNotice of intention to appoint Administrators
29th Dec 20257:30 amRNSSuspension - The Revel Collective plc
29th Dec 20257:30 amRNSSuspension - The Revel Collective plc
23rd Dec 20255:18 pmRNSForm 8.3 - Revel Collective PLC (The)
23rd Dec 20255:18 pmRNSForm 8.3 - Revel Collective PLC (The)
22nd Dec 20259:20 amRNSForm 8.5 (EPT/NON-RI) - Revel Collective PLC
19th Dec 20257:00 amRNSUpdate on Strategic Review and Formal Sale Process
19th Dec 20257:00 amRNSUpdate on Strategic Review and Formal Sale Process
12th Nov 20253:31 pmRNSForm 8.3 - Revel Collective Plc
10th Nov 20255:18 pmRNSForm 8.3 - Revel Collective Plc
10th Nov 20257:02 amRNSForm 8.3 - Revel Collective Plc
7th Nov 202511:33 amRNSForm 8.3 -The Revel Collective Plc
7th Nov 202510:00 amRNSForm 8.3 - Revel Collective PLC
6th Nov 20255:37 pmRNSForm 8.5 (EPT/NON-RI)
5th Nov 202511:10 amRNSForm 8 (OPD) - Revel Collective PLC
5th Nov 20259:33 amRNSHolding(s) in Company
3rd Nov 20252:01 pmRNSForm 8.3 - Revel Collective Plc
31st Oct 20254:00 pmRNSForm 8.3 - Revel Collective Plc
31st Oct 202512:32 pmRNSForm 8.3 - Revel Collective Plc
24th Oct 20257:00 amRNSStrategic Review and Launch of Formal Sale Process
29th Jul 20257:00 amRNSPre-Close Statement
10th Jun 20252:44 pmRNSDirectorate Change - CFO appointment
26th Mar 20257:00 amRNSDirectorate Change
4th Mar 20257:00 amRNSInterim Results
22nd Jan 20257:00 amRNSH1 Update
23rd Dec 20248:59 amRNSDirectorate Change
12th Dec 20242:39 pmRNSIssue of Equity
6th Dec 20249:49 amRNSShare Options and Director/PDMR Shareholding
4th Dec 20247:00 amRNSResult of AGM
8th Nov 20243:34 pmRNSAnnual Report, Notice of AGM and Directorate
28th Oct 20247:00 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSPreliminary Results
17th Oct 202411:40 amRNSNotice of Preliminary Results
16th Oct 20241:01 pmRNSChange of Company Website
14th Oct 20247:00 amRNSDirectorate Changes
13th Mar 201812:55 pmRNSDistribution
8th Mar 201810:54 amRNSResult of EGM
14th Feb 20184:35 pmRNSExtraordinary General Meetings - Correction
13th Feb 20181:00 pmRNSExtraordinary General Meetings
24th Jan 20187:00 amRNSReceipt of Disposal Proceeds
29th Dec 20177:00 amRNSHalf-year Report
21st Dec 201711:21 amRNSResult of AGM
30th Nov 201711:02 amRNSNotice of AGM
17th Nov 20177:30 amRNSSuspension - Trinity Capital Plc
10th Nov 20171:58 pmRNSCompletion of Disposal of Investment
9th Nov 20178:00 amRNSRestoration - Trinity Capital plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.